Price to Earnings Ratio PE Definition & Meaning | Fundamental Analysis | CSIMarket
CSI Market
Sign In | Register

Glossary

Price to Earnings Ratio PE

Fundamental Analysis

The Price to Earnings Ratio P E (PE) is a popular financial ratio used in fundamental analysis to evaluate the relative value of a company*s stock. It measures the market price of a stock compared to the earnings per share (EPS) of that stock.

The formula for calculating the PE ratio is:

PE Ratio = Market Price per Share / Earnings per Share (EPS)

The market price per share can be found by dividing the market capitalization of the company by the number of outstanding shares. The EPS is calculated by dividing the net income of the company by the number of outstanding shares.

The PE ratio is a useful tool to compare the valuation of different companies in the same industry or sector. A high PE ratio may indicate that a company*s stock is overvalued, while a low PE ratio may indicate that it is undervalued. However, it is important to also consider other factors such as the company*s growth prospects, risk profile, and competition.

Investors can use the PE ratio to evaluate whether a stock is worth investing in or if it is overpriced. For example, if a company has a high PE ratio compared to its competitors, it may be a sign that investors have high expectations for future growth. Conversely, a low PE ratio may indicate that a company is undervalued and potentially a good investment opportunity. However, investors should always conduct thorough research before making any investment decisions.




More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P
Get Price to Earnings Ratio PE's full dataset: Subscribe API License